GTx, Inc. (NASDAQ:GTXI)
A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Insider ownership 30% and increasing. Charts look like a whipsaw at the moment but also like a bottom forming, which is consistent with my understanding of insider buying patterns.
Recs
The FDA lifted the clinical hold on Capesaris but the stock hasn't moved. Maybe that's because the lower doses of Capesaris that the company will use in the next trial have already been tried without success. The POWER1 and POWER2 phase III trials of Ostarine continue to enroll with interim data expected in H1 2013. The overall picture is uninspiring but Citigroup loves to manipulate this stock out of its deepest holes with pie-in-the-sky forecasts and price targets. I wonder if I can go along for the ride this time.
Recs
Bio play
Recs
Biotech----Play on the Chart
Recs
Slightly too much of a selloff. Still viable.
Recs
Recs
inisder bought 4.6m worth of shares at 4.75 each. cash rich, zero debt.
Recs
Jan 1 ..Six different directors purchased shares on the open market at $2.65. Seems like confidence. Pure speculation though.
Recs
These guys are toast
Recs
Glimmers of hope- meeting with the FDA to discuss future rulings, drug has technically not been rejected.
Recs
Pharma company with cancer trials. I bet against curing cancer even though that would be great.
Recs
Decision from the FDA by 2/28/08. It would be the first approval of its kind so the stock should rally.
Recs
Promisng treatment for prostate cancer in late-stage development likely to fuel gains for GTXI over the next year or so.
Recs
s+p strong buy, reuters rated out-perform, target price $27
Recs
It has a couple of Phase lll trials going on. It is about ready to pop. Great short term possibilities and great long term too. It has good buzz in the market place. Several reports state it will have unbelievable growth when the products hit the market soon.
Recs
THERE ARE SEVERAL OPTIONS ON THE TABLE NOW. THERE WILL BE AN ANNOUCEMENT APRIL 12-15 CONCERNING THE FINAL TRAILS OF THEIR DRUGS
Recs
ready for the gate
Recs
has taken a beatin lately...but I am still in love with the pipeline.
Recs
great pipeline and collaborations with large pharmas
Recs
This drug is presently being tested for the treatment of prostrate cancer.Eight months ago it was tested on my friend along with a sugar pill the cancer is gone.I'm sure this drug is going to be around for a while.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 22 : 1 2 Next »